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Abstract
Cell migration is a widespread and complex process that is crucial for morphogenesis and for the underlying invasion and
metastasis of human cancers. During migration, cells are steered toward target sites by guidance molecules that induce cell
direction and movement through complex intracellular mechanisms. The spatio-temporal regulation of the expression of
these guidance molecules is of extreme importance for both normal morphogenesis and human disease. One way to
achieve this precise regulation is by combinatorial inputs of different transcription factors. Here we used Drosophila
melanogaster mutants with migration defects in the ganglionic branches of the tracheal system to further clarify guidance
regulation during cell migration. By studying the cellular consequences of overactivated Hh signalling, using ptc mutants,
we found that Hh positively regulates Bnl/FGF levels during embryonic stages. Our results show that Hh modulates cell
migration non-autonomously in the tissues surrounding the action of its activity. We further demonstrate that the Hh
signalling pathway regulates bnl expression via Stripe (Sr), a zinc-finger transcription factor with homology to the Early
Growth Response (EGR) family of vertebrate transcription factors. We propose that Hh modulates embryonic cell migration
by participating in the spatio-temporal regulation of bnl expression in a permissive mode. By doing so, we provide a
molecular link between the activation of Hh signalling and increased chemotactic responses during cell migration.
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Introduction
During embryonic development, signalling pathways modulate
cell behaviour by activating transcriptional programmes in
response to extracellular signals. Over the past 50 years, it has
been shown that surprisingly few pathways regulate these
developmental programmes and that the dysregulation of these
can lead to a plethora of human diseases, particularly to cancer.
One characteristic of these developmental signalling systems is the
selective transcriptional responsiveness of target genes to pathway
activity. One major current challenge is to delineate the molecular
mechanisms by which signalling pathways regulate cell movement
and how this is dynamically coordinated during development.
Cell migration is a widespread and complex process that is
crucial for morphogenesis and for the underlying invasion and
metastasis of human cancers. Research into individual and
collective cell migration, occurring under normal development
or pathological conditions, is likely to yield clinically relevant
insights. During collective cell migration, groups of cells migrate
cohesively and are steered toward target sites by guidance
molecules, stopping at the location where they are required for
biological function. This requires activating target genes in their
proper cellular context, while preventing their expression in other
cells. Thus precise regulation of the expression of these guidance
molecules is of extreme importance for morphogenesis and for
human disease.
In Drosophila melanogaster, collective cell migration is present
during tracheal development, an invertebrate model for tubulo-
genesis. Tracheal cell migration is a model of choice for studying
how extracellular signals transduce into cellular movement [1].
During tracheal development, the main chemoattractant respon-
sible for cell migration is the FGF homologue Branchless (Bnl) [2].
Bnl activates the FGF receptor (FGFR) Breathless (Btl) on tracheal
tip-cells, which lead the concerted migration towards the Bnl
source [3,4]. bnl is expressed in a complex and dynamic pattern in
tissues surrounding the developing tracheal system, thus control-
ling its migration and branching [2]. bnl expression is a
determinant of the earliest branching events to the later
programmes of tracheal gene expression. Two striking features
characterise the expression of this gene during embryogenesis,
namely its spatial complexity and its dynamic nature. However,
very little is known about how the spatial and temporal control of
this expression pattern is achieved. In addition, very few
transcriptional regulators of bnl have been identified to date
[5,6,7]. Therefore the major question remains as to how bnl cell-
specific expression regulation is achieved.
The Hedgehog (Hh) signalling pathway is involved in embry-
onic morphogenesis, axonal guidance and angiogenesis [8]. Early
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studies of this pathway were based exclusively on genetic analysis
of Drosophila melanogaster, though homologues were later found in
many species where they were also found to play fundamental
roles in development and disease [9]. Hh can act as both a short-
range, contact-dependent factor, and a long-range, diffusible
morphogen [8,10]. The binding of Hh to its receptor Patched (Ptc)
relieves Ptc-dependent repression of Smoothened (Smo) to activate
downstream signalling events. Therefore, Ptc acts antagonistically
to Hh, and ptc-loss of function phenotypes are similar to those
observed when hh is overexpressed [8]. Downstream targets of Hh
range from its own receptor Ptc and other signalling molecules like
Decapentaplegic (Dpp) to transcription factors and cell cycle
regulators [11]. Furthermore, activation of Hh signalling has been
linked to several types of cancer [12].
The regulation of Hh signalling is crucial for the maintenance of
proper gene expression in a variety of tissues during growth and
cell survival, differentiation and migration [13,14]. In addition,
many targets of this pathway are expressed only in restricted
domains within Hh-responsive tissues giving rise to the question of
how tissue-specific responses are induced. This can be achieved by
transcriptional control of target gene expression. According to
current models, two ways of achieving this control are: i) by
activator insufficiency, where a transcription factor alone is unable
to strongly activate gene expression and/or ii) by cooperative
activation, which combines signal-regulated transcription factors
with local activators [15].
Here we used D. melanogaster mutants with migration defects in
branches of the tracheal system to study guidance regulation
during cell migration. By examining the functional consequences
of overactivated Hh signalling, using ptc mutant embryos, we
found that Hh modulates bnl transcription levels during embryonic
stages. By doing so, this morphogen controls cell migration non-
autonomously. We show that the Hh signalling pathway regulates
bnl expression via Stripe (Sr), a transcription factor with homology
to the Early Growth Response (EGR) family of vertebrate
transcription factors. We propose that Sr participates in the
regulation of bnl expression in a permissive mode, participating in
the spatio-temporal control of its expression.
Results
patched mutant embryos have tracheal branch
migration/extension defects
In D. melanogaster wild-type (wt) embryos, ganglionic branches
(GBs) form at the lateral/ventral side and target the central
nervous system (CNS) (Fig. 1A0). In an ethyl methanesulfonate
(EMS) genetic screen for genes responsible for tracheal morpho-
genesis, we identified one mutant, D130, where GBs do not extend
into the ventral nerve cord (VNC) and we focused our analysis on
this phenotype (Fig. 1B0). However, defects in dorsal branch (DB)
elongation (Fig. 1B and C9, asterisk) and in dorsal trunk (DT)
thickness and convolution (Fig. 1B–C , arrowheads) were also
observed. In addition, the visceral branches (VBs) were very often
misplaced, localising more ventrally than in the wt (Fig. 1 A and C,
arrows).
Using Bloomington Chromosome 2 deficiency kit, we found
that allele D130 fails to complement Df(2R)ED1742, which deletes
the region 44B8 to 44E3. Candidate gene analysis showed that
D130 also failed to complement previously reported patched (ptc)
mutant alleles. In addition, mutant embryos for the previously
characterised ptcIIw and transheterozygote combinations of ptcD130
with other alleles and Df(2R)ED1742 deficiency displayed the
same GB phenotype (Fig. 1C0 and Fig. S1).
To confirm that ptc is affected in our D130 mutant, the ptcD130
chromosome was sequenced, revealing a change of Q395STOP
(Fig. S1). ptc encodes a 12-pass transmembrane domain protein,
with two large extracellular domains, responsible for binding Hh,
and a smaller intracellular domain, homologous to sterol-sensing-
domain (SSD)-containing proteins. Amino acid (aa) 395 lies at the
end of the first extracellular domain, just before the beginning of
the SSD. ptcD130 encodes a truncated protein (data not shown),
which inferred by comparison to other alleles used in studies of Ptc
function, is unable to bind and internalise Hh [16,17,18].
Tracheal development begins normally in ptc mutant embryos,
as monitored by targeted expression of monomeric Red Fluores-
cent Protein (RFP) fused to moesin (mRFP::moesin, under the
control of the breathless promoter, named btlmoeRFP reporter) in
tracheal cells [19]. Placodes in ptcD130 were correctly positioned
and the first steps of cell migration occurred normally (Fig. 1E, E9).
The initial steps of tracheal development were apparently regular
until embryonic stage 12. At this point, we detected the first defects
in GB extension. During stage 12, in wt and mutant embryos, the
lateral trunk anterior (LTa) and the lateral trunk posterior/
ganglionic branch (LTp/GB) migrated ventrally at the same level
on the lateral side of the embryo (Fig. 1D9, E9). By stage 13, the wt
LTp/GB (Fig. 1 F, asterisk) had advanced towards the ventral side
of the embryo in relation to the LTa (Fig. 1 F, arrow). By wt stage
15, spatial separation between LTa and GB was evident (Fig. 1G,
asterisk marks GB). Nevertheless, in ptc mutant embryos LTa and
LTp/GB showed the same lateral elongation in the embryo until
the end of embryogenesis, and we could not distinguish between
LTp and GB, even at late stage 15 (Fig. 1 H, I).
Thus, ptc mutant GBs have migration/extension phenotypes
indicating that ptc is required for proper GB morphogenesis in the
tracheal system of D. melanogaster.
ptc mutants have lower numbers of tracheal cells
In the wt, no significant tracheal cell division or death is
detected after embryonic stage 11, and tracheal branches maintain
the same characteristic number of cells throughout embryonic
development [20]. However, the Hh pathway has been shown to
regulate cell proliferation and apoptosis during development
[21,22]. Thus, in ptc mutants, the lack of GB migration could be
attributable to specific differences in cell proliferation or apoptosis
in the tracheal system. Therefore, we examined the tracheal cell
number in ptc mutant embryos and compared them with the wt
(Fig. 2 A, B, G, H). From placode stages, ptc mutants showed a
lower number of tracheal cells than wt embryos (Fig. 2 G). On
average, 63 cells per tracheal metamere 5 (Tr5) of stage 13
embryos in ptc (n = 19) in comparison with 97 cells in Tr5 of wt
embryos (n = 11) (Fig. 2 H). However, this lower cell number could
not be correlated with a decrease in GB branch length, because in
cyclin A (cycA) mutant embryos tracheal branches are formed and
migrate to their destinations with only half the normal number of
cells (38 cells, n = 8, Fig. 2C, H) and accomplish a standard tube
diameter and length [23], with GBs invading the VNC as in the wt
(Fig. 2 F). In addition, to rule out the possibility of specific cell
death within the GB, we combined ptcD130 with the H99
deficiency, which deletes the proapoptotic genes reaper (rpr), head
involution defective (hid) and grim. In these mutant embryos, cell death
no longer occurred, but they maintained the same phenotype as ptc
mutants, with GBs not extending into the VNC (Fig. S1). Taken
together, these results show that the ptc GB phenotypes are not
attributable to differences in embryonic tracheal cell numbers.
Hh Modulates FGF Levels
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Specification of GB fate and the formation of tracheal
cellular extensions is not dependent on Ptc activity
By late embryogenesis, ptc mutants do not show any GBs
extending into the VNC. How can Ptc affect this extension? One
possibility could be that in ptc mutants tracheal cells of the LTp/
GB cannot differentiate as proper GB cells and may adopt other
cell fates. To check whether the absence of GBs in the VNC was
caused by cell fate misspecification, we first analysed the presence
of GB-specific markers in ptc mutant embryos. In the wt, GB cells
express the specific marker Complex 2 [20] (Fig. 3 A). Therefore,
we checked the presence of this marker in ptc mutant embryos.
Despite the general disorganisation of the LTp/GB, Complex 2-
expressing cells were detected in this branch (Fig. 3 B, arrows).
This result indicates that GB cells express a proper GB cell
marker. Therefore we can refer to the presence of these branches
in ptc mutants, despite the lack of VNC invasion. Another
explanation could be a change in branch fate induced by higher
levels of Dpp in ptc mutants. Ptc induces dpp expression via Hh
signalling (reviewed in [24]), and Dpp specifies tracheal ventral
fates and dorsoventral migration via knirps (kni) activity [25,26,27].
To check if aberrant migration of GB cells in ptc mutant embryos
is caused by changes in the Dpp signalling pathway, we monitored
the expression of kni (Fig. 3 C, D). In ptc mutants, Kni protein
localisation was unaffected in relation to the tracheal branches and
was detected in the rudimentary dorsal, visceral, lateral and
ganglionic branches (Fig. 3 D, D9). These observations rule out the
possibility that aberrant tracheal migration in ptc mutant embryos
is an indirect consequence of changes in GB cell fate.
Ptc may also affect GB cell migration by limiting the migratory
capacity of these cells. The FGF homologue encoded by the bnl
gene is expressed in cells adjacent to the tip of migrating branches
and tracheal tip-cells react to this chemoattractant by forming
dynamic filopodial extensions [28]. In order to check whether the
absence of GB migration was due to a lack of filopodial extensions,
we analysed the behaviour of ptc embryonic tracheal tip-cells in
vivo. As the GB migrated towards the CNS, cell extensions were
prominently seen in the wt GB tip-cell (Movie S1 and Fig. 3 E,
arrow). In ptc mutants dynamic cell extensions were detected in the
tip-cells (Movie S2 and Fig. 3 F, arrow). In addition, the cytoplasm
Figure 1. Ptc is required for tracheal morphogenesis. (A–C) Stage 16 wt (A) and ptc mutant (B–C) whole-mount embryos stained with the
tracheal lumen antibody 2A12, using HRP immunohistochemistry for visualisation. A and B are dorsal views; A9, B9, C and C9 are lateral views and A0,
B0 and C0 are ventral views. A, A9 and A0 are images of the same embryo; the same for B and C. Arrows indicate the visceral branch (VB), arrowheads
the dorsal trunk (DT) and asterisks the dorsal branch (DB). (D–I) Lateral views of stage 12 to 15 wt (D, F, G) and ptc mutant (E, H, I) btlRFPmoe embryos
stained with an anti-RFP antibody to visualise all tracheal cells. D9 and E9 are magnifications of D and E, respectively. Anterior is left in all panels; scale
bars are 100 mm in D–E and 20 mm in F–I. Arrowheads indicate the lateral trunk anterior (LTa) and asterisks indicate the ganglionic branch (GB).
doi:10.1371/journal.pone.0092682.g001
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of GB tip-cells elongated in both the wt and the mutant (Fig. 3 E–
F, asterisks). These results demonstrate that, in the absence of
functional Ptc, tracheal cells retain the capacity to form filopodial
extensions.
The ptc GB migration phenotype is associated with
earlier tip-cell fate specification
The cell at the tip of each GB behaves as a leading cell and later
differentiates as a terminal cell [7,29]. The process of terminal cell
differentiation requires the activity of the gene blistered (bs, also
known as pruned) encoding the Drosophila Serum Response Factor
(DSRF) [30,31]. Three distinct DSRF enhancer elements were
identified in D. melanogaster. One directs the expression in tracheal
terminal cells and is regulated by bnl; and two were found to drive
expression in wing imaginal discs and are regulated by hh [32].
Thus, ptcmutant GB extension phenotypes could be attributable
to defects in terminal cell fate specification. To further explore this
hypothesis, we analysed DSRF expression in the GBs of ptc mutant
embryos. LTa and LTp/GB cells started expressing DSRF earlier
than in the wt (Fig. 4 A–B). In the latter, tracheal tip-cells began
expressing DSRF, albeit at very low levels, at late stage 13 [33]. In
ptc mutant embryos, DSRF expression was detected at early stage
13 and was fully established by late stage 13 (Fig. 4 B9 compare to
same stage wt in A9). In wt and ptc mutant embryos, cells
expressing DSRF behaved as terminal cells, extending a long
intracellular lumen (Fig. 4 E, F, arrows).
DSRF induction in GB tip-cells is triggered by FGF signalling
through activated MAPK [33]. The FGFR signalling cascade uses
the adaptor protein Downstream-of-FGFR (Dof, also known as
Stumps)[34,35]. Dof expression is restricted to cells that express
FGFRs where it is required to activate the MAPK cascade,
specifically via FGF signalling [34]. Accordingly, we detected a
stronger accumulation of Dof in cells of the LTa and LTp/GB of
ptc mutant embryos in comparison with the same wt cells (Fig. 4
C–D). In the wt, Dof accumulated at higher levels only in the GB
tip-cells (Fig. 4C9, arrow), whereas in ptc mutants, Dof was equally
detected in both LTa and LTp/GB (Fig. 4D9–D0, arrow). In
addition, accumulation in DB tip-cells at stage 13 was greater in ptc
mutants (Fig. 4C9–C0and D9–D0 , arrowheads). This observation
indicates that in ptc mutants, DB, LTa and LTp/GB cells have
higher levels of FGFR pathway activation.
In order to study whether earlier levels of DSRF in tracheal tip-
cells are responsible for the lack of migratory capacity of these cells
towards the VNC, we generated double mutants for ptc and bs
(Fig. 4 H). For this purpose, we used the pruned1 null allele of bs,
which has no functional DSRF, but expresses bgal in all bs-
expressing cells [32] (Fig. 4 G). Analysis of these double mutants
revealed that ptc mutant GB cells were still unable to migrate
despite the absence of functional DSRF (Fig. 4 H). These results
show that changes in DSRF expression in ptc mutants, or the
earlier cell fate changes of these GB cells, are not responsible for
their migratory impairment.
Ptc is present in cells surrounding the GBs
ptc is a D. melanogaster segment polarity gene detected throughout
embryonic development, larval and pupal stages, with no reported
maternal contribution [36,37]. To define the domain of ptc
expression in embryonic tissues during tracheal development, we
used a ptc-lacZ enhancer trap line (Fig. 5 C, D) and a monoclonal
antibody against the first extracellular domain of this receptor
(Fig. 5 A, B), which in normal conditions detects Ptc predom-
inantly in early endocytic vesicles [38]. According to our
observations, ptc-lacZ ßgal expression mimics endogenous Ptc
protein expression throughout all tracheal development stages
(Fig. 5 A–D and Fig. S2). For this reason, we equally used these
two approaches to detect Ptc. At stage 11, Ptc was detected in a
stripe at the anterior portion of each tracheal placode (Fig. 5 A, B)
[39]. Ptc was found in cells surrounding the migrating tracheal
branches (Fig. 5 C and Fig. S2). Later on, Ptc was detected in cells
surrounding the migrating GBs and LTps at stages 12 to 15 (Fig. 5
C, D, arrows and Fig. S2). In many cases, tracheal cells extended
in very close contact to cells strongly expressing Ptc (Fig. 5 C, D).
Using the Ptc antibody, we were unable to detect Ptc expression in
Figure 2. ptc mutants have fewer tracheal cells than wild-type. (A–C) Lateral views of Tr4-Tr7 of stage 13 wt (A), ptc mutant (B) and cycA
mutant (C) embryos stained with anti-Trh antibody to visualise the tracheal nuclei. Nuclei were marked and counted using the Imaris software and
the numbers in each metamere correspond to the number of nuclei marked. Anterior is left. (D–F) Ventral views of stage 16 wt (D), ptcmutant (E) and
cycAmutant (F) whole-mount embryos stained with 2A12 antibody to visualise the tracheal lumen. GBs are present and enter the VNC in cycAmutant
embryos, despite the very low numbers of tracheal cells. Anterior is left. (G,H) Quantification of tracheal cell numbers in wt, ptc and cycA embryos. (G)
Comparison of cell numbers in Tr5 of wt and ptc mutant at stages 11 and 13; Tr5 at stage 11 have an average of 90 cells in the wt (n = 16) and 73 cells
in ptc embryos (n = 18); Tr5 at stage 13 have an average of 97 cells in the wt (n = 11) and 63 cells in ptc embryos (n = 19). (H) Comparison of cell
numbers in Tr5 of wt, ptc and cycA mutants at stage13; Tr5 at stage 11 have an average of 97 cells in the wt (n = 11), 63 cells in ptc embryos (n = 19)
and 38 cells in cycA mutants (n = 8). *P-value#0.01.
doi:10.1371/journal.pone.0092682.g002
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GB cells from stage 13 (not shown). However, we could not discard
the presence of Ptc in these cells at levels below detection by these
methods.
The Hh pathway modulates GB migration non-
autonomously
To test whether the observed defects in GB migration are
dependent on excess Hh signalling by lack of Ptc activity, we used
an engineered form of Ptc, which is composed of the N-terminal
signalling portion of Hh joined via HA tags to the Ptc receptor
[40]. Named Hh-Ptc, this construct behaves as a cell-autonomous
form of Ptc constitutively-bound to Hh, activating the Hh pathway
in all cells where it is expressed [40]. When overexpressed in the
ptc domain of expression, using a ptcGAL4 driver, Hh-Ptc induced
defects similar to those detected in the absence of Ptc (Fig. 5 G). In
addition, expression of a Ci-activated form in Ptc-positive cells also
generated a defective GB phenotype (Fig. S2). These experiments
confirmed that activation of the Hh pathway in Ptc-positive cells is
responsible for the migration phenotypes observed. In order to test
whether the effects of Ptc on the GB phenotypes derived from
within the tracheal cells, we expressed the same Hh-Ptc in all
tracheal cells using btlGAL4 (Fig. 5 H). This ectopic expression did
not induce a significant tracheal phenotype, thereby confirming a
non-autonomous effect of Hh signalling in GB patterning that is
not mediated by the activation of this pathway in tracheal cells. In
order to check whether inhibition of GB migration was due to
excess Hh signalling in cells surrounding this branch, we
misexpressed hh in the VNC of wt embryos, using an inscGAL4
driver [7]. Consistently, this misexpression resulted in the
abrogation of GB migration/extension and in earlier expression
of DSRF, like in ptc mutant embryos, because of increased Hh
signalling in cells within and surrounding the VNC (Fig. 5 K).
In addition to binding Hh to initiate signalling, Ptc also
modulates the extracellular gradient of Hh [38,41]. To analyse
whether changes in this gradient in the cells surrounding tracheal
cells contributed for the GB phenotype, we analysed GB migration
in double mutants for ptc and hh (Fig. 5 F). In ptc;hh embryos GBs
behaved like ptc embryos. This observation sustains that changes in
the Hh gradient are not responsible for the observed phenotype
and confirms that the phenotypes are due to increased levels of Hh
signalling. In hh mutants, when Hh signalling was inhibited, GBs
still invaded the VNC despite the overall morphogenetic defects
(Fig. 5 E). In addition, when the Hh pathway was silenced in Btl-
or Ptc-positive cells by expressing a Hh-insensitive form of Ptc,
PtcDloop2, which constitutively inhibits Smo [18], GB extension
was not affected (Fig. S2).
Taken together, these data indicate a non-autonomous effect of
ptc in GB migration/extension, mediated by increased Hh
signalling in cells surrounding these tracheal branches.
Hh signalling regulates bnl transcription
Like all tracheal branches, GB migration depends on the
dynamic expression of the FGF homologue bnl. Both the absence
and excess of bnl expression can inhibit branch extension/
migration [2]. In ptc mutant embryos, we observed earlier DSRF
expression and higher levels of Dof in all LTa and LTp/GB
(Fig. 4D9 ). For these reasons, we questioned whether the GB
phenotypes observed in ptc mutants could be attributed to changes
in bnl expression.
For Hh signalling to be able to induce bnl mRNA, Ptc is
required in the cells that normally express bnl. Indeed, we detected
Ptc in bnl-expressing cells surrounding the GB (Fig. 6 A–B,
arrows), thus confirming that these cells could activate Hh
signalling.
In ptc mutants, bnl mRNA levels were higher in cells
surrounding the tracheal LTa and LTp at stage 13 and the same
observation was made when hh was overexpressed in the VNC
(Fig. 6 D–E). In addition, when UASHh-Ptc was expressed in ptc-
Figure 3. Ptc is not required for GB fate determination and the
formation of tracheal cellular extensions. (A,B) Stage 16 wt (A)
and ptc mutant (B) embryos carrying the Complex-2-lacZ reporter
stained with the chitin binding probe (CBP) to visualise the tracheal
lumen and the anti-ßgal antibody to mark all GB nuclei. Arrows indicate
Complex-2 positive nuclei. (C–D) Stage 13 wt (C) and ptc mutant (D)
embryos stained with anti-kni (red) and anti-trh antibody to mark all
tracheal nuclei. C9 and D9 are images of the red-channel confocal
projection. Kni expression is detected in cells of dorsal, visceral, lateral
trunk and ganglionic branches, as well as in cells surrounding the LTa
and LTp/GB in wt and mutant embryos. (E–F) Details of the lateral/
ventral side of a live wt (E) and ptc mutant (F) embryo, marked with
CD8::GFP driven by btlGAL4 to visualise cytoplasmic extensions during
cell migration. Long cytoplasmic extensions are formed by the tip-cells
in the wt and mutant GBs. All panels are lateral views. Anterior is left
and scale bars are 10 mm in all panels.
doi:10.1371/journal.pone.0092682.g003
Hh Modulates FGF Levels
PLOS ONE | www.plosone.org 5 March 2014 | Volume 9 | Issue 3 | e92682
expressing cells (Fig. 5 G), the effect on GBs was similar as to when
UASbnl was overexpressed using the same driver (Fig. 6 G).
Moreover, overexpression of Hh or Bnl using ptcGAL4 or twiGAL4
phenocopies the ptc mutant GB migration/extension phenotype
(Fig. 6 F–I).
To more clearly assess the role of the Hh pathway as a regulator
of bnl transcription, we analysed the levels of bnl transcripts by
quantitative Real-Time PCR (qRT-PCR) in whole embryos from
stage 12. Homozygous ptc embryos showed an average of 5.5-fold
increase in the expression of this gene. Consistently, we also
observed a 3-fold increase in bnl transcription upon overexpression
of hh using ptcGAL4. Upon ectopic expression of hh using twiGAL4,
a driver expressing in the mesoderm from stage 6 [42], a 2-fold
increase in bnl expression was detected (Fig. 6 J). As a positive
control, we found a 14.5-fold increase in bnl mRNA levels upon
ectopic expression of bnl using the inscGAL4 line (Table S1 in
Tables S1). Taken together, these results confirm that higher levels
of Hh in cells near the GB and/or activation of the Hh pathway in
cells surrounding the GB increase bnl transcription levels.
Taken together, these results demonstrate that lack of functional
Ptc or overactivation of the Hh pathway induces higher levels of
bnl expression in ptc-expressing cells.
The Hh signalling pathway is epistatic to bnl
In order to further ascertain the upregulation of bnl expression
by the Hh pathway, we analysed the genetic interaction between
ptc and bnl. bnl is a haploinsufficient locus whose products are
present at limiting concentrations in heterozygous (bnl/+) individ-
uals. More than 60% of heterozygous bnl embryos show occasional
missing or stalled branches with the GBs most often affected [2].
Using ptc heterozygous embryos, we analysed whether these
phenotypes are altered by modifying the Hh pathway. We
quantified how many GBs entered the VNC in embryos trans-
heterozygous for ptc and bnl (n = 48) and detected a consistent
increase in comparison with bnl heterozygous embryos (n = 115)
(Fig. 6K–M ). The total average of GBs entering the VNC in bnl
heterozygotes increased from 11 to 15 by removing only one copy
of ptc. This increase was even clearer when the numbers of GBs
entering the VNC were divided into four groups, as shown in Fig. 6
M. Most of the embryos (68.1%) transheterozygous for bnl and ptc
had from 13–20 GBs entering the VNC, in contrast to bnl
heterozygous embryos, which were only 30.2% in this group.
Therefore we can conclude that ptc genetically interacts with bnl
and that higher levels of Hh signalling can overcome the GB
migration defects present in bnl heterozygous embryos.
Hh signalling regulates bnl transcription through the
induction of stripe (sr)
We then addressed whether this regulation of bnl expression by
the Hh signalling pathway was direct or through an intermediate
regulator of bnl expression. Of the many studies on the
downstream effectors of the Hh pathway, none has found Bnl/
FGF to be a direct target of the pathway. In addition, little is
Figure 4. ptc mutants start expressing DSRF earlier. (A,B) Stage 13 wt (A, A9) and ptc mutant (B, B9) embryos carrying the btlmoeRFP reporter
stained with anti-RFP to visualise the tracheal cells and anti-DSRF antibody to mark all terminal-cell nuclei. ptc embryos start expressing DSRF earlier
than the wt. Scale bars are 10 mm. (C,D) Late stage 13 wt (C, C9) and ptc mutant (D, D9) embryos stained with anti-Dof and anti-trh antibody. All ptc
embryos analysed have higher levels of Dof in DB tip-cells (arrowheads in D9 and D0, n = 12). Scale bars are 10 mm. (E,F) Detail of stage 16 GBs stained
with 2A12 and anti-DSRF in wt (E) and ptc embryos (F). (G,H) Detail of stage 16 GBs from embryos carrying the pruned-lacZ reporter stained with
2A12 and anti-ßgal in pruned (DSRF) mutant (G) and double ptc pruned mutant. Terminal cells in pruned mutants do not extend their terminal lumen
in wt or ptc mutant backgrounds (asterisks). Scale bars are 25 mm. DSRF* means that in panels E, F the presence of this protein is detected by the
antibody, whereas in panels G,H terminal cells are marked by bgal expression. Anterior is left in all panels.
doi:10.1371/journal.pone.0092682.g004
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known about the upstream mechanisms that establish the dynamic
expression pattern of bnl.
stripe (sr) encodes a zinc-finger transcription factor of the early
growth response (EGR) family implicated in tendon-cell differen-
tiation [43]. Its dynamic expression is determined by the interplay
between Hh and Wg [44] and is required for the proper migration
of myotubes and tracheal branches [43,45,46]. In addition, sr is
expressed by bnl-expressing cells, and sr null mutants display
tracheal migration phenotypes (Fig. 7 G, H and [46,47]).
Therefore, we examined whether sr could be the effector of Hh
signalling responsible for modulating bnl levels during tracheal
migration. In order to be such an effector, sr needs to be present in
ptc-positive cells and in particular in the same cells that express bnl.
Therefore we analysed the co-expression of sr and ptc in wt
tracheal development stages and concluded that indeed sr is
present in cells expressing ptc (Fig. 7A–B , arrows). Then, we
analysed sr expression in ptc mutant embryos and in embryos
overexpressing hh under the control of twi, in which we had
previously detected a phenotype similar to that of ptc and also
higher levels of bnl expression (Fig. 6). In both cases, broader
domains of sr expression in association with defective GB
migration phenotypes were observed (Fig. 7 C, D and E). In
addition, cell autonomous overactivation of the Hh pathway by
means of Hh-Ptc expression led to higher levels of sr induction
(Fig. 7F ) associated with greater bnl expression in cells surrounding
the LTa and LTp/GB (Fig. 7 G) and defective GB migration
(Fig. 5 G). To conclude, we analysed GB migration and bnl
expression in embryos overexpressing sr in the ptc domain, which
also causes a broader ectodermal sr expression domain [45]. These
embryos showed strong tracheal migration phenotypes from early
stages, ranging from lack of dorsal trunk fusions to general DB and
GB migration phenotypes (Fig. 7 I). Furthermore, higher levels of
bnl expression in cells surrounding the migrating GBs were
detected (Fig. 7 L). These results show that higher levels of Hh
Figure 5. The Hh pathway modulates GB cell migration non-autonomously. (A,B) wt embryos stained with anti-Ptc and anti-Trh antibodies.
Ptc protein is detected in vesicles in Ptc-expressing cells. (C,D) ptclacZ embryos stained with anti-ßgal and anti-Trh. Ptc expression is detected by
nuclear ßgal presence. Scale bars are 50 mm in A and 10 mm in B–D. (E–H) Ventral views of stage 16 embryos stained with 2A12 to visualise the
tracheal lumen. (I–I0) Dorsal, lateral and ventral views of the same stage 16 embryo expressing Hh in the VNC and stained with 2A12. Excess Hh in the
VNC phenocopies the ptc mutant tracheal phenotype, but only on the ventral/lateral side of the embryo. (J–K) btl . tauGFP wt stage 15 embryo
stained with anti-DSRF and GFP (J) and btlmoeGFP stage 15 embryos overexpressing Hh in the VNC and stained with anti-DSRF and GFP (K) or only
DSRF (K9).
doi:10.1371/journal.pone.0092682.g005
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signalling induce broader domains of sr expression and that these
are correlated with greater bnl expression in cells surrounding the
GB.
If this is the case, reduction of sr dosage in a ptc genetic
background should improve the migratory capacity of GB cells
whereas complete removal of Sr should have the same phenotype
either alone or in a ptc genetic background. Indeed, analysis of
double mutants for ptc and sr, proved this to be correct. Removing
one copy of sr in a ptc background rescues the migration of many
GBs (Fig. 7 L), whereas embryos mutant for the two genes have
impaired GB migration, like sr and bnl mutants (Fig. 7 I, J and not
shown). We confirmed the effect of Sr on bnl expression by
Figure 6. The Hh pathway modulates Bnl expression. (A,B) bnl expression in a ptclacZ heterozygous stage 13 embryo also stained with lacZ. (B)
Marked area contains ptc-expressing cells that co-express bnl in cells surrounding the migrating GBs. (B9) Only in situ bnl expression; Rectangle marks
the are depicted in panel B999 for clarity. (B0) Only ptclacZ expression. (B999) Schematic representation of the main areas of bnl expression surrounding
LTa and LTp/GB. (C–E) bnl expression in wt (C), ptc (D) and in embryos expressing Hh in the VNC (E), in stage 13 embryos co-stained with anti-GFP and
anti-Trh to mark all tracheal cells. C9, D9 and F9 show only the bnl in situ hybridisation pattern. (F–I) Ventral views of stage 16 embryos stained with
2A12 to visualise the tracheal lumen. (J) Graphic representation of quantitative Real-Time PCR results. The two columns with the same colour
represent independent experiments using the same genotype. Hashed red line marks 1.5-fold expression. All overexpression experiments induce
greater levels of bnl expression than those in wt. P-values #0.01. (K,L) Ventral views of stage 16 embryos stained with 2A12 to visualise the tracheal
lumen. (M) Quantification of the number of GBs entering the VNC in embryos heterozygous for bnl (red) in comparison with embryos
transheterozygous for ptc and bnl (blue) *P-values #0.01.
doi:10.1371/journal.pone.0092682.g006
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analysing the levels of bnl transcripts by quantitative Real-Time
PCR (qRT-PCR) in whole embryos from stage 12. We observed a
2-fold increase in bnl transcription upon overexpression of sr in the
epidermis using 69BGAL4 (Fig. 7 N and Table S2 in Tables S1).
Taken together, these results show that increasing sr expression in
embryos increases bnl transcription levels.
Finally, to confirm that upregulation of bnl expression is
dependent on Ci, we analysed bnl levels in Ci overexpressing
embryos. We observed a 2-fold increase in bnl transcription in
embryos overexpressing Ci in the ptc domain and a 3-fold increase
in embryos overexpressing Ci in the epidermis using 69BGAL4
(Fig. 7 N and Table S2 in Tables S1).
Altogether, these results indicate that the Hh pathway
modulates GB migration by regulating Bnl via Sr, in a Ci-
dependent manner.
Discussion
Hh and FGF signalling play a key role in normal embryonic
development. In many tumour settings these pathways are
Figure 7. Hh signalling regulates bnl transcription through the induction of stripe (sr). (A, B) Stage 13 (A, A9) and 15 (B, B9) embryos
carrying the ptclacZ reporter stained with anti-bgal, anti-SrB antibody and anti-Trh. Sr is expressed in some ptc-expressing cells, in particular cells
surrounding the Ltp/GB (arrows). At late stages, anti-SrB antibody is unspecifically detected in the tracheal lumen. Scale bars are 10 mm. (C, D) Stage
15 ptc heterozygous (C) or homozygous (D) embryos stained with anti-SrB, anti-GFP and anti-DSRF. The Sr expression domain is enlarged in ptc
mutant embryos. Scale bars are 10 mm. (E, F) Stage 15 embryos overexpressing hh in twi-expressing cells (E) and overexpressing Hh-Ptc in ptc
expressing cells (F) stained with anti-SrB, anti-Trh and anti-DSRF. The Sr expression domain is enlarged in both overexpression experiments. Scale bars
are 10 mm. (G, H) Ventral and lateral view of a stage 15 sr mutant embryo stained with 2A12 to visualise the tracheal lumen. (I) Ventral view of a stage
16 embryo overexpressing sr in ptc-expressing cells stained with 2A12 to visualise the tracheal lumen. (J) Ventral view of a stage 16 ptc mutant
embryo heterozygous for sr stained with 2A12 to visualise the tracheal lumen in black and bgal to mark the TM3ftzlacZ balancer in brown; midline
cells are marked in brown. (K, L, M) bnl expression in stage 13 wt embryos (G), embryos expressing Hh-Ptc (H) and expressing sr (I) in ptc-expressing
cells. Marked area contains trh-expressing cells (from another channel, not shown). Anterior is left in all panels. (N) Graphic representation of
quantitative Real-Time PCR results. The two columns with the same colour represent independent experiments using the same genotype. Hashed red
line marks 1.5-fold expression. All overexpression experiments induce greater levels of bnl expression than those in wt. P-values #0.01.
doi:10.1371/journal.pone.0092682.g007
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dysregulated, and they are also crucial for driving tumour
formation and angiogenesis [12,48]. Due to the relevance of these
signalling cascades during cell migration in various biological
contexts, it is crucial to unveil the upstream and downstream
events that lead to their spatio-temporal regulation. Here we show
that the activation of Hh signalling increases bnl expression levels
in D. melanogaster embryos. Other model systems also show a
dependence of various FGFs on Hh signalling [49,50,51,52,53,54].
However, these connections have only been reported to affect
proliferation/growth and not cell movement.
Hh is present throughout D. melanogaster embryonic develop-
ment where it affects numerous cellular processes [8]. Bnl/FGF
signalling is used repeatedly during tracheal development, where
branch outgrowth is directed toward bnl-expressing non-tracheal
target tissues via chemotactic induction of cell migration [2]. Here
we analysed tracheal cell migration in conditions where the Hh
pathway is overactivated. This allowed us to detect downstream
events that are not evident when using Hh mutant phenotypes.
Loss of function situations are not as effective in identifying
redundant genes or different partners in cooperative transcription
regulation of target gene expression. By analysing embryos in Hh
gain of function conditions we found that Hh signalling is
associated with the modulation of Bnl/FGF levels. In addition, we
identified Sr as an upstream regulator of Bnl/FGF expression in
cells surrounding the GB and showed the importance of Hh
signalling for its expression (Fig. 8).
Hh and tracheal cell migration
Previous lines of evidence have indicated that Hh plays an
active role in tracheal development. In hh mutants, six to eight cells
remain on the ectoderm after invagination, and tracheal placodes
have fewer cells [39]. We also found that in ptc mutant embryos,
fewer cells account for the tracheal tree at later stages,
independently of apoptosis. These observations suggest that Hh
signalling affects tracheal cell fate or proliferation, although
trachealess (trh) expression is not dependent on hh [11].
From embryonic stage 12 onwards, the most severe tracheal
defect previously observed in hh mutant embryos is an impairment
in cell migration. And at later developmental stages, the Hh
pathway was shown to be required for patterning terminal cells in
the dorsal branches [39]. These authors also reported that
compromising the activity of the pathway reduces the extent of
terminal branching, while activation of the Hh pathway gives rise
to an excess of terminal cells in the dorsal branch [39]. Hh has also
been shown to act on terminal cells during their cytoplasmic
extension, exerting its attractive effect from the epidermis [55]. In
the light of our results, we attribute these Hh loss- and gain-of-
function phenotypes to the lower or higher levels of bnl expression
present in hh mutants or when the pathway is overactivated,
respectively.
Here we demonstrate that Hh modulates tracheal cell migration
non-autonomously by regulating bnl expression autonomously.
Overactivated Hh signalling leads to higher levels of bnl in ptc-
expressing cells. Higher levels of this chemoattractant in tissues
surrounding the tracheal tip-cells have the same effect as inhibition
of bnl expression [2]. This is consistent with the classical view that
chemotaxis follows a bell-shaped curve in which excess ligand
inhibits cell movement [56]. More precisely, here we have shown
that overexpression of bnl has the same effect as the absence of bnl
expression in limiting GB migration towards the VNC.
This upregulation of bnl expression also leads to an earlier
expression of DSRF in tracheal cells. Besides, since ptc mutant
trachea have less cells this also means that proportionately more
cells express DSRF. In addition, it can be expected that higher
levels of Bnl will also lead to higher DSRF expression. However,
by imunohistochemical analysis we could not determine if this is
the case. Either way, we have shown that Hh-induced changes in
DSRF levels of expression are not responsible for the lack of
migratory ability of ptc mutant cells.
Tissue-specificity of Hh-dependent bnl regulation
We show that the transcription factor Sr is the effector of Hh
signalling responsible for increased bnl levels in bnl-expressing cells.
We propose that this effect is permissive rather than instructive,
because we did not detect higher levels of bnl expression in all cells
receiving the Hh signal or in those with higher levels of sr
expression. This proposal is supported by previous results showing
that general ectodermal expression of sr does not lead to the
general expression of bnl [46,54]. In view of these observations and
our own results, we suggest that this regulation is achieved cell-
specifically. Essentially, this means that complete regulation of bnl
expression requires another tissue-specific factor that can synergize
with Sr in order to fine-tune its transcription levels (Fig. 8). Our
proposed model is supported by the idea that many cell signalling
pathways such as Hh, Notch and Receptor Tyrosine Kinase
(RTK) are characterised by activator insufficiency, meaning that
pathway activation is necessary, but not sufficient, to fully induce
their transcriptional targets [15]. Furthermore, we propose that bnl
expression is induced by Hh signalling by cooperative activation,
combining a signal-regulated transcription factor (Sr) with a local
activator (X).
What would such complexity in bnl transcription regulation
accomplish? Transcription is a highly regulated process involving
the combined interaction of many factors that control the selective
activation or repression of specific genes. These regulated
interactions ultimately allow a sophisticated response to multiple
environmental conditions, as well as control of spatial and
temporal differences in gene expression. Sr could be the factor
responsible for this control in cells that already have the machinery
required, but not sufficient, to express bnl. Sr is the D. melanogaster
homologue of the Early Growth Response (EGR) vertebrate
transcription factors [57]. Amongst the characteristics of mam-
malian EGR genes are their capacity to be rapidly induced and
their ability to form heterodimers to regulate gene expression [58].
Therefore, we can envisage a scenario where Sr, together with
another factor (we called X in our proposed model, in Fig. 8), is
responsible for the spatio-temporal fine-tuning of the regulation of
bnl expression. Because the expression of this gene is not Hh-
dependent in all cells, we extrapolate from our observations that
the mechanism leading to the spatio-temporal regulation of bnl
transcription involves combinatorial control by Hh-sensitive (like
Sr) and Hh-independent transcription factors.
Early growth response (Egr) genes in the spatio-temporal
regulation of gene expression
We show that Hh signalling leads to the induction of sr
expression and that this transcription factor modulates bnl
expression. sr is required for determining the cell fate of muscle
attachment sites that mark the segment border of the embryo in
response to Ci activation [44,45]. sr is expressed in muscle-
attachment cells, which are responsible for providing guiding cues
for myotube migration [43]. These ectodermal cells generate long-
range signals that are involved in myotube guidance and that
determine their spatial orientation [43,45]. It would be of interest
to determine whether one of these signals is bnl and whether this
growth factor is also involved in myotube guidance.
Sr is homologous to the Egr family of transcription factors [57].
These transcription factors regulate many genes encoding proteins
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of diverse functions within various cell types. A characteristic of the
mammalian Egr genes is that they are rapid and transiently
induced by many mitogenic and differentiation-inducing intercel-
lular signals [59,60].
Egr-1, first discovered as a gene rapidly induced in response to
serum [61], has been shown to regulate FGF2 levels during
angiogenesis and tumour growth [62]. This type of rapid
regulation is also present in the immune system where Egr-1 is
involved in cytokine expression [58]. In addition, the gene
expression of the Egr family is also associated with the rapid
activation of neuronal plasticity-associated transcription [60].
Overall, the Egr family of transcription factors is involved in
responses to physiological stimuli involving rapid changes in gene
transcription. It is therefore reasonable to hypothesise that the Sr
participates in the rapid response to Hh signalling necessary for
the swift changes in bnl expression that are required for tracheal
cell migration.
Figure 8. Proposed model of the role of Hh signalling in the regulation of bnl expression. (A) Model of changes in bnl expression
dependent on Hh signalling in cells surrounding the tracheal tip-cells. Drawn are the LTa and LTp/GB in the wt, ptc mutant and Hh overexpression
scenarios. Both the absence of Ptc activity and overexpression of Hh in cells near the migrating LTp/GB have the same inhibitory effect on GB
migration. This is due to higher levels of bnl expression induced by the Hh pathway. (B) Proposed model for the activation of bnl expression via Sr and
a cell/tissue-specific co-activator. When Hh signalling is active, SrB is one of its target genes being expressed in ptc-expressing cells. When these cells
also express a specific bnl activator (X), bnl expression is induced at high levels. In the absence of Sr, X can drive bnl expression but only at low levels.
The activation of the Hh pathway in addition to the expression of specific local activators is responsible for the fast upregulation of bnl expression in
the tissues surrounding the migrating tracheal cells. According to this model, Sr is involved in the positive regulation of bnl expression in a permissive
mode.
doi:10.1371/journal.pone.0092682.g008
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Conclusions
This study reveals a direct connection between Hh signalling
and the induction of bnl expression, which is accomplished through
the transcription factor Sr, together with another unknown cell-
specific factor. Cell migration in response to FGF signalling must
be carefully regulated and coordinated with other cellular
processes. This delicate balance is probably maintained by tight
control of the temporal and spatial expression patterns of Hh
targets and other cell-specific molecules. Furthermore, both the
absence of Ptc-1 or deregulation of FGF/FGFR activities are
hallmarks of many human cancers accompanied by higher cell
motility and invasiveness [12,48]. For these reasons, it is likely that
the mechanism proposed here for this rapid induction of Bnl/FGF
is also conserved in vertebrates.
Methods
D. melanogaster stocks and genetics
The following stocks are described in FlyBase (http://flybase.
bio.indiana.edu): Df(2R)ED1742, simGal4, twiGal4, srGAL4,
UASsr, 69BGAL4, and UASCD8GFP, hh21, sr155. We also used
ptcIIw, ptclacZ, UAS-Hh and UAS-Hh-Ptc (from A. Casali, Barcelona,
Spain), btlmoeRFP (from M. Affolter, Basel, Switzerland), UASCi
(from T. Orenic, Chicago, USA) and Complex2 (from C.
Samakovlis, Stockholm, Sweden). Wild-type is yw and ptc refers
to ptcD130 unless otherwise stated. We used the GAL4 system [63]
for over or misexpression experiments. inscGal4 (from G.Tear,
London, UK) was used as a VNC driver, btlGAL4 (from M.
Affolter) as a general tracheal driver, ptcGAL4 (from A. Casali) as a
ptc-positive cell driver. Heterozygous embryos were recognized by
lacZ and GFP balancer chromosomes. D. melanogaster stocks and
crosses were kept under standard conditions at 25uC. All
overexpression experiments were conducted at 29uC.
Immunohistochemistry, image acquisition and data
analysis
Embryos were staged as described by Campos-Ortega and
Hartenstein [64] and stained following standard protocols. For
immunostaining, embryos were fixed in 4% formaldehyde for 20-
30 minutes. We used antibodies that recognise GFP (Molecular
Probes and Roche), RFP (abcam), ßGal (Cappel and Promega),
Ptc (from A. Casali), DSRF (Active Motif), Dof (from M. Leptin,
Cologne, Germany), Trh (from J. Casanova, Barcelona, Spain),
SrB (from T. Volk, Rehovot, Israel) and 2A12 (DSHB). We used
HRP, Alexa488, Alexa-555 and Alexa-647, Cy2, Cy3 and Cy5
conjugated secondary antibodies (Jackson ImmunoResearch). For
HRP histochemistry, the signal was amplified using the Vectas-
tain-ABC kit (Vector Laboratories) when required. In addition, the
signal for the DAB reaction was intensified with NiCl2, except for
double stainings, where it was omitted from one of the reactions.
For tracheal lumen visualisation, we also used fluorescently-
conjugated CBP (NEB). In situ hybridisation was performed
following standard protocols. ribo-bnl was generated using the
whole cDNA as a template and using the Megascript kit (Ambion).
Photographs were taken using a Nikon Eclipse 80i microscope.
Fluorescent images were obtained with confocal microscopes
(Leica TCS-SPE-AOBS and Leica TCS-SP5-AOBS system) and
processed using Fiji [65] and Adobe Photoshop (Adobe Systems)
softwares. Images are maximum projections of confocal Z-sections.
Phenotypes were scored using Nomarski optics on a Nikon Eclipse
80i microscope with a 20x or 40x objective. Cells were counted
using Imaris x64 7.6.1 (Bitplane) software.
Time-lapse experiments
btlGal4UAS-CD8GFP (Movies 1 and 2) embryos, wt or ptc
mutant, were mounted for live imaging as described [66]. Z-stacks
(0.5 mm step size) were collected on a Leica TCS-SP5-AOBS
system and processed using Fiji [65]. Sections were recorded every
3 minutes for 6–8 hours.
Real-Time PCR
Real-time PCR was performed with a Roche LightCycler 480
using the SYBR Green I method following the manufacturer’s
instructions. The two sets of primers for bnl and for the rp49 control
were designed on exon-exon junctions to avoid genomic ampli-
fication, using the Primer Express software (Applied Biosystems).
To assess levels of expression, we extracted total RNA from
embryos with Trizol reagent (Invitrogen) following the manufac-
turer’s instructions. ptc homozygous mutant embryos were
separated by means of a GFP balancer. We prepared cDNAs
with the RevertAid H Minus First Strand cDNA Synthesis Kit
(Fermentas) using random hexamer primers. The nature of the
PCR products was confirmed by melting curve analysis. All
analyses were performed using the Relative Expression Software
Tool (REST) following the user manual and references. The main
steps of the automatic REST workflow were as follows: PCR
efficiencies were calculated for each pair of primers by generating
standard curves at increasing dilutions of cDNA (1:2, 1:4, 1:8,
1:16) and used to correct raw data. rp49 was assumed to be equally
expressed in wt and mutant/overexpressing embryos and was used
as a reference to normalise data. A ratio between the normalised
signals of tested genes in mutant and wt embryos was calculated
and expressed as fold increase/decrease, and statistically tested by
a bootstrap test (10000 randomisations). We used a sample size of
3 repeats per plate, for each embryonic genotype tested, using a set
of primers for bnl, and each experiment was repeated twice.
Supporting Information
Figure S1 Different allelic combinations of ptc have the
same phenotype and inhibition of apoptosis does not
change the GB phenotype. (A–E) Stage 16 wt (A), ptcIIw
mutant (B), ptcD130 over the deficiency that deletes ptc (C), ptcD130
over the deficiency that deletes grim, reaper and hid (D) and ptcD130
heterozygous embryos stained with the tracheal lumen antibody
2A12, using HRP immunohistochemistry for visualization. A B, C,
D and E are dorsal views; A9, B9, C9, D9 and E9 are lateral views
and A0, B0, C0, D0 and E0 are ventral views. (F) Sequence
comparison between the wild-type and ptc D130 mutant; detection
of the base difference that leads to an early STOP codon.
Represented are nucleotides 1918 to 2067 of the ptc cDNA.
(TIF)
Figure S2 Ptc is expressed in cells surrounding the
migrating tracheal branches and inactivation of the Hh
pathway does not affect GB migration. (A–F) Different stage
embryos expressing ptclacZ stained with anti-ßgal and anti-Trh. Ptc
expression is detected by nuclear bgal presence. Scale bars are
10 mm. Panels B, D and F show a single Z-section. (G–I) Ventral
views of stage 16 embryos stained with 2A12 to visualize the
tracheal lumen.
(TIF)
Movie S1 Wild-type GB migration and generation of
filopodial extensions. wild-type embryo carrying btlGAL4 and
UASCD8GFP constructs to reveal tracheal cell morphology and
cytoplasmic extensions. One tip-cell is present at the tip of each
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GB as it migrates towards the VNC. This cell extends long
filopodial extensions in response to FGF signalling.
(AVI)
Movie S2 ptc mutant GB migration and generation of
filopodial extensions. ptc mutant embryo carrying btlGAL4
and UASCD8GFP constructs to reveal tracheal cell morphology
and cytoplasmic extensions. One tip-cell is present at the tip of
each GB as it tries to migrate towards the VNC. This cell extends
long filopodial extensions in response to FGF signalling, but is not
able to advance in the VNC direction.
(AVI)
Tables S1 Supporting tables. Table S1, qRT-PCR Results.
Table S2, qRT-PCR Results.
(DOCX)
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